By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ARTES Biotechnology 

Elisabeth-Selbert-Str. 9

Langenfeld    40764  Germany
Phone: 49-0-2173-27587-0 Fax: 49-0-2173-27587-77



Company News
ARTES Biotechnology And Boehringer Ingelheim Animal Health Announce Collaboration 3/16/2015 10:37:42 AM
ARTES Biotechnology, InstrAction And Q-Biologicals Join Forces For Veterinary Vaccine Development 10/6/2014 8:12:17 AM
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014 8:50:14 AM
ARTES Biotechnology Release: TA101 GOCLIN European Funded Project For The Development Of An Innovative Product For The Treatment Of Rheumatoid Arthritis – 1,7M€ Total Budget 12/23/2013 10:45:50 AM
ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development 7/15/2013 9:39:49 AM
ARTES Biotechnology and Midas Pharma GmbH Signed Cooperation Contract 6/24/2013 9:37:08 AM
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013 10:38:33 AM
ARTES Biotechnology Announces a Strategic Collaboration Deal for Vaccine Development 4/24/2012 9:54:26 AM
ARTES Biotechnology Steps Further into the Vaccine Business by Acquiring Anavax 9/27/2010 12:35:40 PM
Q Chip Ltd And ARTES Biotechnology Announce Collaboration to Develop New Injectable Sustained Release Formulations of Therapeutic Proteins 4/30/2010 1:43:27 PM